Skip to main content
User menu
Cart
Login
DIAL.pr - BOREAL
Search form
Search
Home
All Publications
Export
Help
Date
1
2022
Apply 2022 filter
1
2021
Apply 2021 filter
Access
2
Accès libre
Apply Accès libre filter
You are here
Home
»
Search
»
Search results
»
sm_creator:"Aregay, Mehreteab"
»
Search
Accès à distance ? S'identifier sur le proxy
UCLouvain
Search
Sort by
Relevancy
Publication date desc
Publication date asc
Creation date
Fulltext
Displaying
2
results.
Speech
Trastuzumab deruxtecan in patients with HER2-overexpressing locally advanced, unresectable, or metastatic colorectal cancer (mCRC): A randomized, multicenter, phase 2 study (DESTINY-CRC02).
Raghav, Kanwal Pratap Singh
Yoshino, Takayuki
Guimbaud, Rosine
Chau, Ian
Van den Eynde, Marc
[UCL]
Maurel, Joan
Tie, Jeanne
Kim, Tae Won
Yeh, Kun-Huei
Barrios, Daniel
Kobayashi, Kojiro
Bako, Emarjola
Aregay, Mehreteab
Meinhardt, Gerold
Siena, Salvatore
(2021)
2021 ASCO Annual Meeting I —
Speech
Trastuzumab deruxtecan in patients with HER2-overexpressing locally advanced, unresectable, or metastatic colorectal cancer (mCRC): A randomized, multicenter, phase 2 study (DESTINY-CRC02).
Raghav, Kanwal Pratap Singh
Yoshino, Takayuki
Guimbaud, Rosine
Chau, Ian
Van den Eynde, Marc
[UCL]
Maurel, Joan
Tie, Jeanne
Kim, Tae Won
Yeh, Kun-Huei
Barrios, Daniel
Kobayashi, Kojiro
Bako, Emarjola
Aregay, Mehreteab
Meinhardt, Gerold
Siena, Salvatore
(2022)
2022 ASCO Gastrointestinal Cancers Symposium —
